MoneyWorks4Me

Medico Remedies informs about investor presentation

11 Jan 2024 Evaluate

Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Medico Remedies has informed that it enclosed Investor Presentation for Q2 FY 2023-24 of the Company.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1224.50
Cipla 1337.00
Lupin 1925.00
Zydus Lifesciences 1127.85
View more..